Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ·Healthcare·Biotechnology
$30.89
+1.25%
Mkt Cap $559.55M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $68.70M | $69.80M | +1.60% | $1.33 | $1.14 | -14.29% | — | — |
| Q4 2025 Nov 4, 2025 | $68.42M | $69.46M | +1.52% | $0.93 | $1.46 | +56.99% | — | — |
| Q3 2025 Aug 5, 2025 | $62.31M | $101.69M | +63.20% | $1.97 | $3.28 | +66.50% | — | — |
| Q2 2025 May 6, 2025 | $48.32M | $53.33M | +10.38% | $0.14 | $0.63 | +350.00% | — | — |
| Q1 2025 Mar 4, 2025 | $57.59M | $57.60M | +0.01% | $0.30 | $0.80 | +166.67% | — | — |
| Q4 2024 Nov 7, 2024 | $47.42M | $55.31M | +16.63% | $0.06 | $0.70 | +1066.67% | — | — |
| Q3 2024 Aug 6, 2024 | $33.42M | $36.84M | +10.24% | -$0.37 | -$0.06 | +83.78% | — | — |
| Q2 2024 May 7, 2024 | $31.28M | $29.53M | -5.58% | -$0.30 | -$0.50 | -66.67% | — | — |
| Q1 2024 Mar 5, 2024 | $34.10M | $35.79M | +4.96% | $0.02 | $0.04 | +100.00% | — | — |
| Q4 2023 Nov 7, 2023 | $29.78M | $28.13M | -5.53% | -$0.70 | -$0.30 | +57.14% | — | — |
| Q3 2023 Aug 1, 2023 | $25.70M | $26.89M | +4.61% | -$0.80 | -$0.40 | +50.00% | — | — |
| Q2 2023 May 2, 2023 | $24.07M | $26.07M | +8.31% | -$0.90 | -$0.80 | +11.11% | — | — |
| Q1 2023 Mar 7, 2023 | $36.52M | $51.28M | +40.39% | -$0.70 | $0.10 | +114.29% | — | — |
| Q4 2022 Nov 3, 2022 | $22.61M | $22.41M | -0.88% | -$1.30 | -$1.10 | +15.38% | — | — |
| Q3 2022 Aug 2, 2022 | $23.65M | $29.82M | +26.06% | -$1.20 | -$0.80 | +33.33% | — | — |
| Q2 2022 May 3, 2022 | $17.58M | $16.73M | -4.79% | -$1.20 | -$1.60 | -33.33% | — | — |
| Q1 2022 Mar 1, 2022 | $21.90M | $20.41M | -6.80% | -$1.30 | -$1.30 | +0.00% | — | — |
| Q4 2021 Nov 2, 2021 | $23.56M | $21.54M | -8.56% | -$1.00 | -$1.20 | -20.00% | — | — |
| Q3 2021 Aug 3, 2021 | $20.37M | $26.27M | +28.94% | -$1.10 | -$0.80 | +27.27% | — | — |
| Q2 2021 May 5, 2021 | $1.46B | $81.02M | -94.44% | $0.10 | $2.20 | +2100.00% | — | — |